✦ LIBER ✦

A phase III study of rhGM-CSF in patients receiving aggressive chemotherapy (CT) for small cell lung cancer (SCLC)

✍ Scribed by Alexopoulos, C.G.; Vaslamatzis, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accelerated CDE chemotherapy with GM-CSF

✍ Ardizzoni, A.; Verturini, M.; Sertoli, M.R.; Mariani, G.L.; Pennucci, M.C.; van 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Preliminary results of a randomised phas

✍ Gatzemeier, U.; Thomas, P.; Cardenal, F.; Snijder, R.J.; Samaras, N.; Melo, M.J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

80 Dose-intensification of V-ICE chemoth

✍ W.P. Steward; J. Von Pawel; U. Gatzemeier; N. Thatcher; J. Frisch 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Risk factors of death due to bone marrow

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Standard vs. high-dose epirubicin in com

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase II study of Topotecan (TC) in pati

✍ Tvede, K.; Ardizzoni, A.; Dombemowsky, P.; Postmus, P.; Buitenhuis, M.; Wanders, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB